An Open-Label Study to Evaluate the Effect of a High-Fat Meal on the Pharmacokinetics of Doravirine/Islatravir (100 mg/0.25 mg) Fixed-dose Combination Tablet and to Compare the Pharmacokinetics of Doravirine/Islatravir to Doravirine and Islatravir Single Entities in Healthy Adult Participants
Latest Information Update: 10 Dec 2024
Price :
$35 *
At a glance
- Drugs Doravirine (Primary) ; Doravirine/islatravir (Primary) ; Islatravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Merck Sharp & Dohme
- 10 Dec 2024 New trial record